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Neuronal differentiation requires a coordinated intracellular response to diverse extracellular stimuli, but the role of specific
signaling mechanisms in regulating this process is still poorly understood. Soluble guanylate cyclases (sGCs), which can be
stimulated by diffusible free radical gasses such as nitric oxide (NO) and carbon monoxide (CO) to produce the intracellular
messenger cGMP, have recently been found to be expressed within a variety of embryonic neurons and implicated in the
control of both neuronal motility and differentiation. Using the enteric nervous system (ENS) of the moth, Manduca sexta,
we examined the role of NO and NO-sensitive sGCs during the migration and differentiation of an identified set of migratory
neurons (the EP cells). Shortly after the onset of their migration, a subset of EP cells began to express NO-sensitive sGC
activity (visualized with an anti-cGMP antiserum). Unlike many neurons in the central nervous system, the expression of
sGC activity in the EP cells was not transient but persisted throughout subsequent periods of axon elongation and terminal
branch formation on the gut musculature. In contrast, nitric oxide synthase activity (visualized using NADPH–diaphorase
histochemistry) was undetectable in the vicinity of the EP cells until the period of synapse formation. Manipulations
designed to alter sGC and NOS activity in an in vivo embryonic culture preparation had no discernible effect on either the
migration or axonal outgrowth of the EP cells. In contrast, inhibition of both of these enzymes resulted in a significant
reduction in terminal synaptic branch formation within the postmigratory neurons. These results indicate that while
NO-sensitive sGC activity is expressed precociously within the EP cells during their initial migratory dispersal, a role for
this signaling pathway can only be demonstrated well after migration is complete, coincident with the formation of mature
synaptic connections. © 1998 Academic Press
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INTRODUCTION
Nitric oxide (NO) is a free radical gas that serves as an
essential signaling molecule in many tissues and organs.
Originally identified as the endothelial-derived relaxing
factor that regulates smooth muscle tension in blood ves-
sels (Ignarro et al., 1987; Palmer et al., 1987), NO has now
been shown also to serve as an intercellular messenger in
macrophage-induced cytotoxicity (Schmidt and Walter,
1994; Stuehr and Nathan, 1989) and as a novel type of
membrane-permeable neurotransmitter in the nervous sys-
tem (reviewed in Bredt and Snyder, 1992; Garthwaite and
Boulton, 1995). The generation of NO is usually accom-
plished by members of the nitric oxide synthase (NOS)
family, dimeric hemoproteins that oxidize L-arginine to
produce NO (Nathan and Xie, 1994; Marletta, 1994). The
presence of NOS in the vertebrate central nervous system
(CNS) was first identified in cerebellar brain slices (Bredt
and Snyder, 1989; Garthwaite et al., 1988; Radomski et al.,
1990). Subsequently, isoforms of NOS (or NOS-like activi-
ties) have been described in numerous brain regions (Bredt
et al., 1990), and NO-dependent signaling has been impli-
cated in a variety of neural functions, including synaptic
plasticity, nociception, spatial memory, and sensory pro-
cessing (reviewed in Schmidt and Walter, 1994; Snyder,
1992). While NO can act on a variety of target molecules
(Hess et al., 1993; Stamler, 1994), the best-characterized
substrates are the soluble guanylate cyclases (sGCs), a
family of heme-binding proteins that, when activated, gen-
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erate cyclic GMP (cGMP; Garbers and Lowe, 1994). cGMP
can in turn influence the regulation of a diverse array of
effector proteins via the activation of cGMP-dependent
protein kinase (PKG; Wang and Robinson, 1997), cGMP-
sensitive ion channels (Finn et al., 1996; Zagotta and
Siegelbaum, 1996), or other potential downstream targets
(Degerman et al., 1997; Palacios et al., 1995; Rayer et al.,
1990).
In addition to their expression in the mature nervous
system, both NOS and NO-sensitive sGCs can be detected
during embryonic development. For example, NOS activity
has been localized to immature cells within the vertebrate
olfactory epithelium, retina, and peripheral sensory ganglia
(Dawson et al., 1991; Ward et al., 1994; Vaid et al., 1996),
while sGCs have been found in a variety of brain regions
throughout much of embryogenesis (Markerink-Van Itter-
sum et al., 1997; Smigrodzki and Levitt, 1997). Notably, the
developmental expression of these enzymes in many neu-
rons is transient, coinciding with particular stages of em-
bryogenesis and often overlapping with periods of axonal
outgrowth and synaptogenesis (Bruning and Mayer, 1996;
Hindley et al., 1997; Roskams et al., 1994; Truman et al.,
1996). Based on observations of this type, a role for NO-
mediated signaling in the developing nervous system has
been proposed in which target cells respond to innervating
processes with the activation of NOS and the production of
NO. Once generated, NO can then freely diffuse into
adjacent cells and modulate one or more intracellular
signaling pathways (including the stimulation of sGC ac-
tivity), thereby providing a retrograde signal that may
regulate the stability of newly formed neuronal connections
(Edelman and Gally, 1992; Gally et al., 1990). Subsequent
manipulations of both NOS and sGC activity in the devel-
oping nervous system have indicated that components of
this signaling pathway may affect neuronal differentiation
in a variety of ways, including the guidance of axons to their
appropriate targets (Ientile et al., 1996; Roskams et al.,
1994), activity-dependent refinement of synaptic connec-
tions by elimination of inappropriate projections (Cramer et
al., 1996; Wang et al., 1995; Wu et al., 1994), and regulation
of synaptic maturation (Kalb and Agostini, 1993).
However, interpretation of the specific role that NO-
mediated signaling may play in the developing nervous
system has been complicated by the contrasting effects that
NOS and sGC activity can have on different classes of
neurons. Depending on the experimental context, NO or
NO-sensitive sGCs have been shown to stimulate neurite
growth (Hindley et al., 1997; Verge et al., 1992), inhibit or
reverse outgrowth (Hess et al., 1993; Renteria and
Constantine-Paton, 1996; Wu et al., 1994), or in some
instances have no effect whatsoever (Mize et al., 1997). In
yet another instance, afferent innervation has been sug-
gested to downregulate NOS expression within target cells
(Baader and Schilling, 1996). Thus, the precise function of
NOS and NO-sensitive GCs within the nervous system
may vary with respect to developmental context and cell
type.
In addition to their expression in the mammalian nervous
system, NOS-related activities have been detected in a
variety of invertebrates (Lin and Leise, 1996; Muller, 1997;
Muller and Bicker, 1994), indicating that this signaling
pathway is evolutionarily conserved. Isoforms of both NOS
and sGCs have now been isolated and characterized in the
insect nervous system (Liu et al., 1995; Nighorn et al., 1998;
Simpson et al., 1997), where the patterns of expression of
these enzymes can be characterized within individually
identifiable cells. For example, subsets of both motor neu-
rons and sensory neurons in the developing locust nervous
system have been shown to express sGC activity tran-
siently around the time of their maturation and synapto-
genesis (Truman et al., 1996). In an elegant recent study,
Gibbs and Truman (1998) showed that the formation of
retinotopic projections in Drosophila requires the activa-
tion of sGC activity within the photoreceptor neurons,
presumably in response to NO released from cells within
the optic ganglia. Interestingly, interference with this sig-
naling mechanism resulted in excessive growth of the
photoreceptor axons into inappropriate regions of the brain,
suggesting that in this instance NO may serve to stabilize
the general location of the growth cones in the optic ganglia
until a subsequent period of synaptic refinement (Gibbs and
Truman, 1998).
In this paper, we have investigated the role of NOS and
sGC signaling with respect to the control of neuronal
migration. For these studies, we used a well-
characterized example of neuronal migration within the
enteric nervous system (ENS) of the moth, Manduca
sexta. As previously described (Copenhaver and Taghert,
1991), the formation of the ENS involves the differentia-
tion of a defined population of neurons (the EP cells) that
arise en masse from a neurogenic placode in the foregut,
forming a packet of postmitotic but immature neurons on
the superficial gut musculature. The subsequent devel-
opment of the EP cells is noteworthy in that it involves
three distinct phases of motile behavior (Fig. 1): a period
of cell migration (during which the neurons disperse
along a set of preformed muscle bands), a period of axon
elongation (when the neurons cease migrating but con-
tinue to elaborate axons along the pathways), and a period
of terminal outgrowth (during which the neurons sprout
terminal synaptic branches onto the adjacent visceral
musculature; Copenhaver and Taghert, 1989a,b). Accord-
ingly, we have examined the developmental expression of
NO-sensitive sGC activity in the developing ENS
throughout these three developmental periods. We have
also identified potential sources of NO near the develop-
ing ENS, using NADPH– diaphorase histochemistry as
marker for NOS (Dawson et al., 1991; Hope et al., 1991).
Last, we have used an embryonic culture preparation to
test whether the NO-sGC signaling pathway participates
in the regulation of EP cell motility and differentiation. A
preliminary report of these findings was presented in
Copenhaver and Wright (1997).
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MATERIALS AND METHODS
Animal Culture and Manipulation
A laboratory colony of M. sexta was maintained as previously
described (Copenhaver and Taghert, 1989a). Newly fertilized eggs
were collected and incubated at 25°C, at which temperature 1% of
development is approximately equivalent to 1 h. Staging of em-
bryos was performed using an established schedule of external and
internal markers (Copenhaver and Taghert, 1989). Embryos were
dissected and cultured in a modified culture medium (50% Schnei-
der’s Drosophila medium, 40% Hank’s MEM, 10% fetal calf serum,
0.2% ecdysone, 0.1% insulin, 0.01% penicillin–streptomycin; after
Horgan et al., 1994). For manipulations of EP cells in vivo, staged
embryos were restrained in Sylgard chambers and a glass electrode
was used to create a small opening in the dorsal ectoderm imme-
diately over the developing ENS. Pharmacological reagents were
then introduced into the body cavity such that the EP cells were
directly exposed to these compounds. Embryos were then allowed
to develop overnight at 28°C. At the conclusion of each experi-
ment, animals were dissected open and fixed with 4% paraformal-
dehyde in phosphate-buffered saline (PBS) for 1 h. Reagents used in
these experiments included the NOS inhibitors NG-nitro-L-
arginine (N-arginine) and NG-nitro-L-arginine methyl ester (L-
NAME; Calbiochem); the guanylate cyclase inhibitors 6-anilino-
5,8-quinolinedione (LY83583; Calbiochem) and 1-H-(1, 2,
4)oxadiazolo(4,3-a)quinaloxin-1-one (ODQ; Biomol); methylene
blue chloride (MB; Polysciences, Inc.); the cGMP analogs dibutyryl-
cGMP (dB-cGMP) and 8-bromo-cGMP (8Br-cGMP; Sigma); the
heme oxygenase inhibitor protoporphyrin IX zinc(II) (ZPP IX;
Aldrich); and 4-bromophenacyl bromide (4-BPB; Sigma), a reagent
used to inhibit phospholipase A2 and DAG lipase activity (Glaser et
al., 1990; Morton and Simpson, 1995).
Histochemistry and Immunohistochemistry
Fixed embryos were rinsed in PBS–Tween 20 (PBST; 0.6%),
preblocked in PBST plus 10% normal serum, and incubated in
primary antibody in blocking buffer at 4°C overnight. Tissues were
then exposed to either an Oregon green-conjugated secondary
antibody (Molecular Probes) or a biotinylated secondary antibody
followed by avidin–biotin–horseradish peroxidase (HRP; Vector
Laboratories), which was then reacted with 39,39-diaminobenzidine
tetrachloride (DAB; Sigma) in the presence of H2O2.
The monoclonal antibody TN-1, which recognizes the Manduca
form of the adhesion molecule Fasciclin II (MFas II), was obtained
from Dr. Paul Taghert. MFas II immunoreactivity was expressed by
the EP cells throughout development and was used to visualize the
extent of their migration and process outgrowth. The polyclonal
antiserum DSYT2, generated against a region of the Drosophila
synaptotagmin protein (Littleton et al., 1993; gift of Dr. Hugo
Bellen), was used both to monitor the extent of synaptogenesis
following culture experiments and to indicate the degree of matu-
ration of the EP cells. To visualize the distribution of synaptotag-
min, we used an Oregon green-conjugated secondary antibody to
detect bound DSYT2 and imaged the preparations using a Leica
TCS NT confocal microscope at the Oregon Regional Primate
Research Center (Beaverton, OR). For visualizing the expression of
nitric oxide-sensitive guanylate cyclases, we treated dissected
embryos with the nitric oxide donor sodium nitroprusside (SNP;
0.1 mM) in the presence of the phosphodiesterase inhibitor
3-isobutyl-1-methyl xanthine (IBMX; 0.1 mM; Sigma) for 15 min
(Truman et al., 1996). cGMP was detected using a rabbit polyclonal
antibody against cGMP (gift of Drs. H. W. M. Steinbusch and J. De
Vente). As previously shown (Ewer et al., 1994; Nighorn et al.,
1998), this antiserum is highly specific for cGMP with little or no
cross-reactivity with cAMP. The peroxidase color reaction used
with this primary antibody included nickel chloride. For double
labeling with TN-1 and the anti-cGMP antiserum, we first visual-
ized the anti-cGMP antibody using DAB plus NiCl2, followed by
TN-1 detection using DAB alone. This treatment resulted in a
blue–black staining of the anti-cGMP antiserum and a yellow–
brown detection of TN-1, yielding a light stain of the entire
population of EP cells and a dark stain of a subpopulation of these
neurons.
To visualize the developmental expression patterns of NOS
activity associated with the ENS, we performed NADPH–
diaphorase histochemistry (NADPHd) after the method of Hope et
al. (1991). Briefly, fixed embryos were exposed to PBS containing
0.2% Triton X-100, 0.5 mM nitroblue tetrazolium (NBT), and 1
mM b-NADPH for approximately 4 h and then rinsed in PBS plus
Triton X-100. Periodically, we also employed alternative fixation
procedures to investigate the possibility of diaphorase inactivation
as a result of incomplete fixation. In addition to our normal fixation
protocol of 4% paraformaldehyde for 1 h, we varied the fixation
time from 20 min to 3 h; we also used an alternative fixation
solution of 4% paraformaldehyde plus 0.1% glutaraldehyde. Em-
bryos fixed in glutaraldehyde were subsequently immersed in 30%
sucrose for 1 h. As noted below, however, none of these fixation
protocols produced qualitatively different patterns of diaphorase
staining from that observed with 4% paraformaldehyde (see Dis-
cussion). Following all of these histochemical procedures, embryos
were mounted in medium (90% glycerol, 0.1% n-propyl gallate,
and 5 mM Hepes) and photographed at 6503 through a compound
microscope with the appropriate filter sets.
Analysis of EP Cell Motility and Outgrowth
Camera lucida drawings were made of embryos stained with
TN-1 and/or anti-cGMP. From these drawings, we measured the
distance migrated by the leading EP cell and the maximal distance
of axon outgrowth along each of the dorsal muscle band pathways
from the foregut–midgut boundary. Experimental values were then
normalized to matched control preparations for each experiment.
The extent of dendritic branching was measured after the method
of Weeks and Truman (1986). An acetate transparency marked with
a 5-mm2 grid (corresponding to a 25 mm2 area within the embryo)
was overlaid on the C. lucida drawings. The number of grids
containing EP cell-derived processes on the foregut or interband
regions of the midgut was counted and averaged for each experi-
mental group. Statistical analyses were performed using an un-
paired Student’s t test. Histograms in this paper indicate mean
values 6 SEM.
RESULTS
Developmental Expression of NO-Sensitive sGC
and NOS Activity in the ENS
To determine whether NO-sensitive sGCs are present in
the developing ENS, we treated staged embryos with the
NO donor SNP to stimulate sGC activity and then immu-
nostained the preparations with an antiserum that specifi-
cally recognizes cGMP (De Vente et al., 1987). Our results
revealed that sGC activity in the EP cells is developmen-
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tally regulated coincident with their migration and out-
growth (Fig. 1). As previously described (Copenhaver and
Taghert, 1989b, 1990), the EP cells emerge from a neuro-
genic placode in the foregut and then spread bilaterally at
the foregut–midgut boundary, prior to the onset of their
migration (from 40 to 55% of development). During this
period, no inducible cGMP immunoreactivity was detected
in the EP cells (Fig. 1, 50%), although some staining
appeared in processes within the recurrent nerve (RN) that
are formed by neurons in the anterior enteric ganglia
(described below). Intense staining was also seen in other
regions of both the CNS and PNS (not shown). Subse-
quently, however, as the EP cells commenced their migra-
tion onto the midgut (from 55 to 60% of development), a
subset of these neurons acquired substantial levels of sGC
activity (Figs. 1 and 2). The onset of detectable levels of
immunoreactivity within the migratory population oc-
curred relatively rapidly (over ;5% of development) and
was distributed throughout the immunoreactive cells and
their leading processes soon after its initial appearance. In
the absence of exogenous NO, cGMP levels throughout the
embryonic ENS were too low to be detected, with the
exception of relatively faint staining within the recurrent
nerve (not shown).
Following the completion of migration, a subset of EP
cells continued to exhibit strong levels of NO-sensitive
sGC activity during the period of axon elongation (from 60
to 75% of development; Fig. 1 and Fig. 2E). Inducible cGMP
immunoreactivity could be seen throughout the somata
and axons of these neurons as they grew along the surface of
the gut. Interestingly, only about half of the EP cells that
migrated onto the midgut were immunoreactive at any
particular stage of development. EP cells that migrated
laterally onto the foregut also acquired detectable levels of
sGC activity during this period, although contrary to the
cell populations migrating onto the midgut, virtually all of
these neurons eventually expressed inducible cGMP immu-
noreactivity (Figs. 1 and 3).
The presence of sGC activity in the developing ENS
suggested that NOS expression might also be associated
with the developing gut. In many systems, the presence of
NOS can be detected in fixed tissues by merit of its ability
to reduce nitroblue tetrazoleum in the presence of NADPH
(the diaphorase reaction), producing a bright blue reaction
product (Dawson et al., 1991; Hope et al., 1991; Scherer-
Singler et al., 1983). We therefore used NADPHd histo-
chemistry to test for NOS activity in the vicinity of the
migratory EP cells during their migration and axon out-
growth. As previously described by Truman et al. (1996), we
observed robust levels of diaphorase activity in a number of
neurons within the CNS (not shown). Surprisingly, how-
ever, no NADPHd staining could be detected in either the
migrating EP cells or the adjacent gut musculature through-
out this period of development (Fig. 2).
Toward the completion of their axon outgrowth, the EP
cells commence a third phase of motile behavior, during
which they extend lateral branches onto the adjacent vis-
ceral musculature to form mature synaptic contacts (from
70 to 90% of development; Fig. 1). In the present study, we
observed that by 90% of development the EP cells on the
foregut had grown a diffuse set of processes onto the radial
foregut muscles, while EP cells on the midgut had formed a
loose network of terminal branches on the interband mus-
culature between the migratory pathways (Figs. 1 and 3). As
in earlier stages, NO-sensitive cGMP staining was distrib-
uted throughout the somata and processes of immunoposi-
tive cells, including the varicose endings of their terminal
branches on the gut musculature (Figs. 3B, 3D, and 3F). No
detectable cGMP immunostaining was seen within the EP
cells in the absence of SNP pretreatment (not shown). In
contrast to the absence of positive NADPHd reactivity
during earlier stages of development, punctate diaphorase
FIG. 1. Developmental expression of NO-sensitive sGC activity in the migratory EP cells. Camera lucida images drawn from staged
embryos that were pretreated with SNP and then immunostained with an anti-cGMP antiserum to show the distribution of NO-sensitive
sGC activity in the developing ENS at specific stages of embryogenesis (noted as percentage of total development, where 1% development 5
1 h real time). Each panel shows a dorsal view of the exposed embryonic gut; RN indicates the recurrent nerve of the foregut. Prior to the
onset of their migration (50% of development), the EP cells form a packet of neurons on the foregut that has spread bilaterally along the
foregut–midgut boundary (double arrow). At this stage of development, no NO-sensitive sGC activity can be detected in the EP cells;
immunostained processes within the recurrent nerve are derived from more anterior enteric ganglia (out of view). Between 55 and 60%,
subsets of EP cells migrate rapidly along a set of eight preformed muscle bands on the midgut (L1–L4 and R1–R4; only the dorsal four bands
are shown), while other EP cell groups migrate laterally along radial muscle fibers on the foregut (muscle fibers not shown); arrows indicate
the direction of migration. During this period, a subset of the EP cells begin to express detectable levels of inducible cGMP
immunoreactivity (indicated in black). By 65% of development, approximately 50% of the neurons on the midgut and most of the EP cells
on the foregut show strong levels of inducible cGMP immunoreactivity throughout their somata and growing processes; all of the foregut
EP cells were found to be immunopositive by 70%. Between 65 and 75%, the postmigratory neurons on the midgut continue to extend long
axonal processes along the eight muscle bands of the midgut (arrows); EP cells on the foregut and near the foregut midgut boundary (in the
nerve arches spanning adjacent muscle bands) also extend a diffuse set of processes onto the adjacent visceral musculature (arrowheads).
Between 75 and 90% of development, the EP cells commence a third phase of motility, during which axon outgrowth on the midgut is
terminated and the neurons sprout a diffuse set of varicose terminals onto the adjacent interband musculature. Varicosities are also
elaborated from the processes of EP cells that have migrated onto the foregut. Intense cGMP immunoreactivity can be detected within the
axons and terminal processes of the EP cells throughout development. Scale bar, 50 mm.
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staining could now be detected on the visceral muscles of
the foregut, in the vicinity of the terminal branches of the
adjacent neurons (Fig. 3C). On the midgut, however, diaph-
orase activity was restricted to an intense but narrow band
of staining within the visceral mesoderm, adjacent to the
foregut–midgut boundary (Figs. 3E and 3G).
Recently, several studies have indicated that diaphorase
staining may not always be a reliable marker for NOS
activity, due to the sensitivity of different cells to particular
fixation procedures (Gonzalez-Hernandez et al., 1996; Vaid
et al., 1996). To control for this possibility in the developing
ENS, we applied a series of fixation protocols shown to
increase diaphorase activity in other systems (see Materials
and Methods). None of these alternative procedures yielded
significant differences in the pattern of diaphorase activity
in the ENS, although a noticeable decrease in staining was
apparent with extended fixation times; however, this de-
creased sensitivity was offset by allowing the color reaction
to continue overnight. All diaphorase staining both in the
CNS and on the gut was completely eliminated when
NADPH was omitted from the reaction (not shown).
Elsewhere in the developing ENS, a variety of neurons
exhibited developmentally regulated sGC expression that
colocalized with diaphorase activity to varying degrees.
Subsets of neurons in the frontal ganglion (FG) and hypo-
cerebral ganglion (HG) on the anterior foregut showed
intense cGMP immunoreactivity following SNP pretreat-
ment during the formation of these ganglia (Figs. 4 and 5). In
the absence of SNP, only two to four cells showed compara-
tively weak immunostaining (not shown). At intermediate
stages (55–65% of development), a substantially larger
number of immunopositive cells could be seen in these
ganglia than in the mature embryo, indicating that some of
the neurons exhibited transient patterns of sGC expression
while others maintained sGC activity after completing
their differentiation. By 90% of development, NADPHd
activity was also observed in a subset of neurons in the
frontal ganglion (Fig. 5C), although we were unable to
determine whether these diaphorase-positive cells also ex-
pressed sGC activity. Within the recurrent nerve on the
foregut, three additional neurons (fn1, fn2, and fn3) were
labeled with the cGMP antibody from their time of initial
outgrowth, and they retained sGC activity throughout their
differentiation (Figs. 4, 5D, and 5E). cGMP immunoreactiv-
ity continued to be distributed throughout the somata and
processes of these neurons, including the varicose endings
of their finest branches that formed on the visceral muscles.
Toward the end of embryonic development, NADPHd ac-
tivity also was detectable in the vicinity of these terminal
processes, forming a pattern of parallel bands of diaphorase
staining on the adjacent foregut musculature (Fig. 5F).
Last, NO-sensitive sGC activity was also detected within
the branches of the proctodeal nerves (arising from cells
within the abdominal ganglia of the CNS; Reinecke et al.,
1978). The leading processes of these neurons exhibited
inducible cGMP immunoreactivity at the time of their
initial growth onto the hindgut (Fig. 5G) and remained
immunopositive throughout their subsequent elaboration
of processes on the hindgut and midgut musculature (Fig.
5H). In older embryos, intense NADPHd staining was seen
in the epithelium of the posterior midgut, including the
region of the midgut underneath the proctodeal nerve
projections (Fig. 5I). Thus, with the exception of the EP cell
populations that had migrated onto the anterior midgut,
NO-sensitive sGC expression within the different regions
of the ENS was regionally colocalized with putative sources
of NOS activity in the mature embryo.
Manipulations of sGC and NOS Activity Do Not
Affect Cell Migration or Axonal Elongation
The appearance of inducible cGMP immunoreactivity
within the EP cells during their migration suggested that
activation of NO-sensitive sGCs might play a role in
regulating one or more aspects of motility in these neurons.
We therefore used an embryonic culture preparation to
FIG. 2. Comparison of anti-cGMP immunohistochemistry and NADPH–diaphorase histochemical staining in the ENS during EP cell
migration. Photomicrographs of matched sets of embryos collected at specific developmental stages during EP cell migration and axon
outgrowth onto the midgut (age indicated as percentage development). MFas II (A, D, G, J): embryos that were immunostained with an
anti-MFas II antibody to show the complete distribution of the EP cells and their processes; cGMP (B, E, H, K): embryos were pretreated
with SNP and then fixed and stained with an anti-cGMP antiserum; NADPH-D (C, F, I, L): embryos were fixed and processed for diaphorase
staining (see Materials and Methods). 58% (A–C): at the onset of EP cell migration, subsets of neurons have traveled onto the midgut muscle
bands (arrows indicate direction of migration; only L1 and R1 are shown), but no detectable NO-sensitive sGC activity was seen in the EP
cells or their processes. Positive staining was seen in processes within the recurrent nerve (rn, arrowheads) that originated in the more
anterior enteric ganglia (out of view). No diaphorase staining was apparent in either the neurons or the surrounding gut musculature. 60%
(D–F): as migration continued, subsets of the midgut EP cells began to show detectable levels of NO-inducible cGMP immunoreactivity,
but diaphorase staining remained negative. 65% (G–I): following the completion of migration, the midgut EP cells continued to extend
axonal processes along the muscle band pathways (see also Fig. 1); cGMP immunoreactivity could be detected throughout both their somata
and processes. Open arrows in H indicate unstained EP cells on L1 and R1; open arrows in I indicate a similar position on the unstained
muscle bands of a diaphorase-reacted preparation. 70% (J–L): as axon outgrowth along the posterior muscle bands of the midgut continued,
strong levels of inducible cGMP immunoreactivity colocalized with the MFas II-positive axons of the EP cells (black arrows; compare J and
K); in contrast, NOS activity remained undetectable on the developing midgut (black arrows indicate a similar position as in J and K). Paired
black bars indicate the foregut–midgut boundary, where appropriate. Scale bar, 20 mm.
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FIG. 4. Developmental expression of NO-sensitive sGC activity in the anterior enteric ganglia and recurrent nerve. Camera lucida images
of preparations immunostained with anti-cGMP antisera following SNP treatment. Each panel shows a dorsal view of the anterior foregut;
immunopositive neurons and processes are indicated in black. FG, frontal ganglion; HG, hypocerebral ganglion; FGC, frontal ganglion
connectives (to the brain); RN, recurrent nerve; fn1, fn2, and fn3, three identified neurons (arrowheads) that differentiate within the recurrent
nerve. Embryonic age indicated as percentage of development. Scale bar, 50 mm.
FIG. 3. Comparison of anti-cGMP immunohistochemistry and NADPH– diaphorase histochemical staining during the maturation of
the ENS. (A) At 65% (after the completion of migration), the majority of the EP cells on the foregut pathways showed positive
anti-cGMP immunostaining following SNP treatment; positive staining could also be seen in processes within the recurrent nerve
(rn). (B) At 90% of development, the foregut EP cells had extended a diffuse, branching arbor (arrowheads) onto the adjacent radial
muscle fibers of the foregut. (C) NADPH– diaphorase histochemistry at 90% of development produced a punctate pattern of staining
associated with the radial muscle fibers of the foregut in the vicinity of the terminal branches of the foregut EP cells (compare with
B). (D) By 90% of development, the EP cells on the midgut muscle bands had also extended varicose terminal processes both along the
muscle bands and onto the adjacent interband musculature (arrowheads). (E) By 90% of development, an intense band of diaphorase
staining (black arrows) was apparent within the visceral mesoderm at the foregut–midgut boundary; open arrows indicate the
approximate position of the stained EP cells shown in D (muscle bands L1 and R1). (F) A higher magnification of the same preparation
shown in D (arrowheads in D and F indicate similar positions). (G) A higher magnification of the same preparation shown in E; note
the unstained EP cells that are faintly detectable on the midgut muscle bands (open arrows). Thread-like structures labeled “t” are
unstained tracheal processes. Paired black bars indicate the foregut–midgut boundary, where appropriate. Scale bar, 50 mm for D and
E and 20 mm for all other panels.
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FIG. 5. Comparison of anti-cGMP immunohistochemistry and NADPH–diaphorase histochemical staining in the anterior enteric ganglia
(A–C), foregut (D–F), and at the midgut–hindgut boundary (G–I). (A and B) Anti-cGMP immunostaining in the frontal ganglion (fg) and
hypocerebral ganglion (hg) at 60 and 90% of development, respectively (compare with Fig. 4). (C) NADPH–diaphorase staining of the frontal
ganglion at 90% of development. (D and E) Anti-cGMP immunostaining in two of the foregut neurons (fn2 and fn3; arrowheads) that develop
within the recurrent nerve (rn) at 60 and 90%, respectively. (F) NADPH–diaphorase staining of the foregut in the vicinity of the neurons shown
in E; black arrows indicate rows of punctate staining in the foregut musculature; open arrows indicate position of the recurrent nerve (unstained).
(G and H) Anti-cGMP immunostaining of the proctodeal nerve branches (arrowheads) extending onto the hindgut and posterior midgut at 60 and
90% of development, respectively. (I) NADPH–diaphorase staining in the visceral mesoderm of the posterior midgut (arrows) in the vicinity of
the proctodeal nerve branches shown in H. Pairs of small black bars in G–I indicated midgut–hindgut boundary. Scale bar, 20 mm.
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investigate the effects of compounds known to affect the
NOS–cGMP signaling pathway. The premigratory EP cells
(at 52–53% of development) were exposed to each reagent in
vivo, and the embryos were then allowed to develop for an
additional 16 h through the completion of neuronal migra-
tion and axon outgrowth. Surprisingly, when the prepara-
tions were analyzed, none of the compounds tested showed
any significant effect on neuronal development. For ex-
ample, N-arginine is a potent inhibitor of NOS (Moncada et
al., 1991), yet it had no effect on EP cell migration (Fig. 6,
dark histograms) or axon outgrowth (light histograms) at
concentrations as high as 500 mM. Similarly, embryos
exposed to a variety of compounds at concentrations known
to inhibit NO-sensitive sGCs, including methylene blue
(MB; 100 mM), ODQ (at 50 mM), and LY83583 (LY; 20 mM),
developed normally when compared to cultured controls
(Fig. 6). The concentrations used in these studies were
previously shown to be effective at blocking insect NOS
and sGC activity, respectively (e.g., Gibbs and Truman,
1998; Nighorn et al., 1998). At higher doses, methylene blue
(1 mM) and LY83583 (100 mM) did perturb EP cell develop-
ment, but they also caused a general disruption of embry-
onic development and were therefore assumed to be non-
specific at these concentrations.
In other systems, additional intercellular messengers in
addition to NO have been shown to stimulate guanylate
cyclases, including carbon monoxide (CO; generated by
heme oxygenase) and arachidonic acid (AA; generated by
DAG lipase). To test whether these alternative signaling
pathways might modulate EP cell development, we cul-
tured embryos in the presence of 4-BPB, an inhibitor of
phospholipase A2 and DAG lipase (Glaser et al., 1990;
Morton and Simpson, 1995), or ZPP-IX, an inhibitor of
heme oxygenase (Grundemar and Ny, 1997). However,
neither of these compounds had any significant effect on EP
cell migration or axon outgrowth (Fig. 7). Conversely, to
test whether activation of cGMP-dependent signaling path-
ways would affect EP cell motility, we cultured embryos in
the presence of the nonhydrolyzable cGMP analogs dB-
cGMP and 8-Br-cGMP (each at concentrations up to 1 mM);
however, neither of these compounds produced any detect-
able effect (Fig. 7).
In summary, the foregoing experiments indicate that
despite the robust expression of sGC activity within the EP
cells that persists throughout the period of their migration
and axon outgrowth, the NOS–sGC signaling pathway does
FIG. 7. Effects of compounds that can modulate cGMP levels on
EP cell migration and axon outgrowth. Histograms show the
distance traveled by the leading EP cells on the midgut (dark bars)
or their axonal processes (light bars) in embryos treated in culture
with the listed compounds. 4-BPB, 100 mM; ZPP-IX, 10 mM;
dBcGMP, 1 mM; 8-Br-cGMP, 1 mM. Data analysis as described in
the legend to Fig. 6; none of the experimental values were signifi-
cantly different from controls.
FIG. 6. Effects of compounds that affect NOS and sGC activity on
EP cell migration and axon outgrowth. Histograms show the
distance traveled by the leading EP cells on the midgut (dark bars)
or their axonal processes (light bars) in embryos treated in culture
with the listed compounds. Diagram above the histograms indi-
cates the primary site of action of each of the inhibitors. N-Arg
(N-arginine), 500 mM; MB (methylene blue), 100 mM; ODQ, 50 mM;
LY (LY83583), 20 mM. Each data set was normalized to matched
sets of embryos incubated in culture medium alone; histogram
values indicate the means 6 SEM as a percentage of the matched
control values for each experiment. N $ 10 for each histogram; no
experimental values were significantly different from controls
(unpaired Student’s t test).
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not appear to regulate the motility or guidance of these
neurons in any detectable manner.
Inhibition of sGC and NOS Activity Perturbs the
Formation of Mature Synaptic Branches
As previously noted, the EP cells are unusual in that they
continue to exhibit inducible cGMP immunoreactivity
throughout embryogenesis, unlike the transient patterns of
sGC activity seen in many other neurons (Gibbs and
Truman, 1998; Giuili et al., 1994; Truman et al., 1996). We
therefore investigated whether sGC activity might play a
role in later aspects of EP cell differentiation, including the
subsequent outgrowth of their terminal processes and the
formation of synapses on the adjacent visceral musculature.
An additional set of embryonic cultures was initiated at
70% of development, after the period of EP cell migration
but prior to the formation of their mature terminal arbors
(see Fig. 1). After 20 h in culture, the preparations were
briefly treated with SNP and then immunostained for both
MFas II and cGMP. The combined application of these two
antisera produced a more robust labeling of fine terminal
processes than either antiserum alone, permitting an accu-
rate assessment of the total extent of outgrowth by neurons
expressing NO-sensitive sGC activity on both the foregut
and midgut.
As shown in Fig. 8, inhibitors of both NOS and sGC
activity had a significant effect on the maturation of several
neuronal classes within the ENS. On the foregut, we found
that the formation of mature arbors by neurons within the
recurrent nerve (fn1, fn2, and fn3; see Fig. 1) proceeded
normally in control cultures (Figs. 8A and 8B; only fn2 and
fn3 are shown). In contrast, treatment with either
N-arginine (to inhibit of NOS activity; Fig. 8C) or ODQ (to
inhibit sGC activity; Fig. 8D) resulted in a substantial
reduction in terminal branch formation exhibited by these
neurons. Similarly, differentiation of the postmigratory EP
cells in cultured embryos proceeded normally on both the
foregut (compare Figs. 8E and 8F) and the midgut (compare
Figs. 8I and 8J), whereas exposure to either N-arginine (Figs.
8G and 8K) or ODQ (Figs. 8H and 8L) inhibited the elabo-
ration of their terminal processes on the lateral muscula-
ture. As noted above, similar concentrations of these inhibi-
tors have been shown to block NOS and sGC activity in
several different insect preparations (Gibbs and Truman,
1998; Nighorn et al., 1998). In addition, when we applied 50
mM ODQ to embryos at 65% of development for 30 min and
then fixed and immunostained the preparations with the
anti-cGMP antiserum (after SNP treatment), we found that
detectable sGC activity was completely eliminated (data
not shown). However, some recovery of functional sGC
activity was apparent by the completion of the 20-h culture
period, as evidenced by the reappearance of inducible cGMP
immunoreactivity (Fig. 8). Neither ODQ nor N-arginine
produced any obvious signs of necrosis or cell death.
To quantify these effects, we also measured the density of
terminal branches extended by the postmigratory neurons
onto the lateral gut musculature (see Materials and Meth-
ods). As shown in Fig. 9, both N-arginine (at 500 mM) and a
second NOS inhibitor, L-NAME (at 500 mM) caused signifi-
cant reductions in the extent of synaptic arbor that was
produced by the EP cells, whereas all other aspects of their
differentiation appeared normal. Similarly, both ODQ
(which selectively inhibits sGCs via oxidation of the heme
group; Schrammel et al., 1996) and LY83583 (which inhibits
sGCs via the generation of hydroxyl radicals; Luo et al.,
1995) induced concentration-dependent reductions in ter-
minal outgrowth (Fig. 9). The more potent effect of
LY83583 may be due to the fact that this compound has
also recently been shown to perturb NOS activity (Luo et
al., 1995). With the exception of the highest concentration
of LY83583 (50 mM), which produced some nonspecific
deleterious effects on embryonic development, none of
these compounds affected the level of MFas II expression in
the EP cells or induced neuronal death.
In addition, we examined the maturation of synaptic
terminals in these cultures by immunostaining the em-
bryos with DSYT2, a polyclonal antiserum against Dro-
sophila synaptotagmin (Littleton et al., 1993). At 70% of
development (the stage used at the beginning of this experi-
ment), we observed relatively little synaptotagmin immu-
noreactivity within the EP cell population, with only a
sparse pattern of punctate staining appearing within the
postmigratory cell populations and their axonal projections
(Fig. 8M). By the completion of the culture period, however,
control animals exhibited a greatly increased level of syn-
aptotagmin expression throughout the processes of the
postmigratory EP cells, as well as punctate immunostaining
associated with the terminal branches of these cells on the
interband regions of the midgut (Fig. 8N). In contrast,
FIG. 8. Effects of compounds that inhibit NOS and sGC activity on the outgrowth of terminal synaptic branches by the postmigratory EP
cells. (A–L) Double-immunostaining with anti-MFas II and anti-cGMP antisera; (M–P) confocal images of antisynaptotagmin immuno-
staining with an Oregon green-conjugated secondary antibody (see Materials and Methods). Panel columns show examples of immuno-
staining in culture preparations that were fixed at the onset of each experiment (Preculture, at ;70% of development), at the end of the
culture period in embryos incubated with normal medium (Control), or in embryos treated at the onset of the culture period with either
N-arginine (500 mM) or ODQ (50 mM). (A–D) Terminal outgrowth of the foregut neurons fn2 and fn3 (arrowheads; compare with Fig. 1). (E–H)
Terminal outgrowth of EP cell groups that had migrated radially out onto the foregut musculature. (I–L) Terminal outgrowth of EP cell
groups that had migrated onto the middorsal muscle bands (L1 and R1). (M–P) Distribution of immunoreactive synaptotagmin in the
processes of EP cell groups that had migrated onto the middorsal muscle bands (similar position as shown in I–L); “t” indicates
autofluorescent tracheal processes. Scale bar, 20 mm.
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embryos treated with either N-arginine (Fig. 8O) or ODQ
(Fig. 8P) showed markedly reduced levels of synaptotagmin
immunoreactivity when compared with control cultures.
These results support our analysis of terminal outgrowth by
camera lucida techniques (described above), demonstrating
that inhibition of either NOS or sGC activity reduces the
growth of mature synaptic arbor by the postmigratory EP
cells on their adjacent visceral muscle targets.
In summary, our results indicate that despite the appear-
ance of NO-sensitive sGC activity in the EP cells during
their initial migration, the NOS–cGMP signaling pathway
does not appear to serve any essential role throughout the
periods of EP cell migration and axonal outgrowth. Instead,
our data support the hypothesis that one or more sGCs
participate in the regulation of subsequent aspects of EP cell
differentiation, including the outgrowth of terminal
branches on their presumptive muscle targets and the
establishment of mature synaptic contacts.
DISCUSSION
NO-Sensitive sGC and NOS Activity in the
Developing ENS
The results of this paper show that NO-sensitive sGCs
are abundantly expressed in the developing ENS of
Manduca and that the timing of this expression coincides
with periods of neuronal motility and outgrowth. In par-
ticular, we found that during the development of the EP
cells, approximately half of these neurons commenced the
expression of sGC activity during their migratory phase of
development and remained NO-sensitive throughout their
maturation. None of these neurons exhibited detectable
levels of GC activity in the absence of NO stimulation.
Because the EP cells are not individually identifiable
(Copenhaver and Taghert, 1989a), we could not determine
from these experiments whether all EP cells on the midgut
acquired NO sensitivity for transient periods of develop-
ment. However, because the percentage of neurons express-
ing this activity remained relatively constant (;50% of the
total population), we believe that a specific subset of EP
cells normally acquires NO-sensitive sGC activity as they
migrate onto the midgut and maintains this expression
throughout their maturation. In contrast, all of the EP cells
that migrated onto the foregut musculature expressed in-
ducible cGMP immunoreactivity in the course of their
differentiation (Figs. 1 and 3). Heterogeneity within the EP
cell population has similarly been documented with respect
to the neurotransmitter phenotypes that they normally
acquire upon the completion of their migratory phase
(Copenhaver et al., 1996; Copenhaver and Taghert, 1989a).
Notably, the pattern of NO-sensitive sGC expression in
the EP cells differs in several ways from the appearance of
cGMP immunoreactivity that has been documented in the
developing insect CNS. Within the ventral ganglia of lo-
custs, for example, subsets of motor neurons were found to
acquire NO-sensitive sGC activity during embryogenesis,
but generally only after they had extended axons to their
presumptive target muscles (Truman et al., 1996). Onset of
NO-sensitive sGC activity in these cells corresponded to
the maturational phase of their development, during which
the motor neurons extended terminal branches across their
target muscles. Similarly, in the developing adult visual
system of Drosophila, ingrowing photoreceptors become
responsive to NO only after their axons have arrived in the
optic lobes but before mature synaptic connections have
been established (Gibbs and Truman, 1998). In contrast,
NO-sensitive sGC activity appeared in the EP cells shortly
after the onset of migration, a stage when these neurons are
still relatively undifferentiated (Copenhaver and Taghert,
1989b). Within the responsive neurons, the distribution of
this activity appeared uniform from the time of its initial
expression, with cGMP immunoreactivity being detectable
throughout their axons and terminal processes as well as in
the cytoplasm of the somata (Figs. 1–3). Unlike many
central neurons in locusts (Truman et al., 1996) and flies
(Gibbs and Truman, 1998), in which sGC activity is tran-
siently expressed and then subsequently downregulated,
sGC expression persisted in the EP cells throughout the
completion of embryogenesis.
Elsewhere in the ENS, we detected additional subsets of
neurons that exhibited NO-sensitive sGC activity in a
developmentally regulated manner. In particular, a substan-
tial number of cells within both the frontal ganglion and
hypocerebral ganglion on the foregut acquired intense lev-
els of inducible cGMP immunoreactivity during their dif-
ferentiation (Figs. 4 and 5). Many of these neurons appeared
FIG. 9. Analysis of the extent of terminal synaptic arbor formed
by the EP cells in the presence of compounds that affect NOS and
sGC activity. Embryos were placed in culture at 70% of develop-
ment and incubated in either control medium (“C”) or with the
following compounds, as indicated: L-NAME (500 mM), N-arginine
(“N-Arg”; 500 mM), ODQ (20 and 50 mM); and LY83583 (“LY”; 10,
20, and 50 mM). After fixation and immunostaining, the density of
synaptic arbor was measured (see Materials and Methods) and
normalized with respect to matched controls for each experiment.
Histograms indicate means 6 SEM. N $ 20 for L-NAME, N-Arg,
and ODQ; N $ 10 for LY83583. *P # 0.01; **P # 0.001.
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to express sGC activity for only a short period of develop-
ment, similar to the transient patterns of NO-sensitive sGC
expression seen in the CNS of both vertebrates (Bredt and
Snyder, 1992) and invertebrates (Truman et al., 1996).
However, as with the migratory EP cells, the neurons
within the anterior enteric ganglia exhibited inducible sGC
activity during their initial stages of axonal outgrowth,
rather than delaying their expression of sGCs until the time
of target innervation as seen in the CNS (Truman et al.,
1996). Similarly, sGC activity could be detected throughout
development in the foregut neurons fn1, fn2, and fn3 (Figs. 4
and 5) and in the axons of neurons within the abdominal
ganglia that formed the proctodeal nerve of the hindgut and
posterior midgut (Fig. 5). This pattern of precocious sGC
expression within neurons of the developing ENS, prior to
the time of target innervation, is thus distinct from that
seen in the developing CNS.
In contrast, the appearance of NADPHd activity (as a
measure of putative NOS expression) was consistently
delayed with respect to the expression of sGC activity in
the ENS. Onset of diaphorase staining in neurons within
the frontal ganglion (Fig. 5C) and associated with the
foregut musculature (Figs. 3C and 5F) appeared only during
the last 25% of embryogenesis. A faint stripe of NADPHd
histochemistry could be detected within the midgut epithe-
lium at the foregut–midgut boundary at as early as 55% of
development (not shown), but only gradually intensified
over the latter half of development (Fig. 3E). Surprisingly,
no apparent sources of NOS-related activity could be de-
tected by diaphorase histochemistry in the immediate vi-
cinity of the EP cell populations that had migrated onto the
midgut (Fig. 3), whereas everywhere else in the ENS posi-
tive NADPHd staining was consistently found near neuro-
nal structures exhibiting NO-sensitive sGC activity. The
possible significance of this observation is discussed below.
Identity of sGC and NOS Activities in the ENS
The histochemical procedures used in this study to detect
sGC and NOS activities in the developing ENS have gener-
ally been considered to be valid measures of these enzymes
in other systems (e.g., De Vente et al., 1987, 1990;
Gonzalez-Hernandez et al., 1996; Ward et al., 1994). For
example, inducible cGMP immunoreactivity has been used
to demonstrate the presence of NO-sensitive sGCs in
vertebrates (De Vente and Steinbusch, 1992; Markerink-
Van Ittersum et al., 1997) and invertebrates (Kuzin et al.,
1996; Truman et al., 1996), while NADPHd histochemistry
has been reported to colocalize with NOS (or NOS-related
activities) in the developing nervous system (Hope et al.,
1991; Kharazia et al., 1994). Nevertheless, verification of
the true identity of these molecules in the ENS will require
characterization of the genes encoding sGCs and NOS in
Manduca and an analysis of their expression during EP cell
development. Recently, Morton and colleagues (Nighorn et
al., 1998; Simpson et al., 1997) isolated cDNA clones
encoding a number of different isoforms of sGC-related
proteins from the moth CNS, including homologues to both
the a- and b-subunits of heterodimeric mammalian sGC. In
a preliminary study, we have now used probes derived from
these two clones to show that both subunits are expressed
in subsets of the migratory EP cells (unpublished observa-
tions). These results support our data on the appearance of
inducible cGMP immunoreactivity in the developing ENS,
indicating that the EP cells commence the expression of
NO-sensitive sGCs in the course of their migration.
In contrast, the true identity of the molecules being
labeled by NADPHd histochemistry is less well defined.
Whereas the presence of fixation-resistant diaphorase stain-
ing in the vertebrate nervous system has often been shown
to correspond to NOS (Hope et al., 1991; Kharazia et al.,
1994), the reliability of this method may vary with respect
to different cell types and fixation procedures (e.g.,
Gonzalez-Hernandez et al., 1996; Vaid et al., 1996). In the
present study, we observed no significant changes in diaph-
orase staining when a variety of different fixation protocols
were applied to the developing ENS. It is also possible that
the level of NOS activity in the vicinity of the migratory EP
cells was simply too low to be detected by the diaphorase
method or that the window of NOS expression associated
with the midgut was too narrow to be documented in the
timeline used for this study. However, we did observe good
colocalization of diaphorase staining with NO-sensitive
sGC activity elsewhere in the ENS (Figs. 3 and 5), suggest-
ing that our methods were sufficient to detect relatively
faint levels of NADPHd activity. Perhaps coincidentally,
detectable levels of diaphorase staining were similarly ab-
sent in the vicinity of the growing processes of motor
neurons in the insect CNS that express NO-sensitive sGC
activity (Truman et al., 1996). Proper characterization of
authentic NOS within the developing ENS and its relation-
ship to the patterns of diaphorase staining that we have
reported will require an analysis of NOS gene expression in
the developing ENS. The recent isolation of cDNA clones
encoding several NOS-like molecules in Manduca (Nighorn
et al., 1998) should facilitate these studies.
Role of NOS–cGMP Signaling in the Developing EP
Cells
The appearance of NO-sensitive sGC activity in the EP
cells shortly after the onset of their migration led us to test
whether the NOS–cGMP signaling pathway might regulate
either the migration or subsequent axon elongation of these
neurons. However, none of the reagents that we used to
inhibit or stimulate this signaling pathway caused any
detectable perturbation of EP cell motility during these
initial phases of their development (Figs. 6 and 7). In
contrast, inhibitors of both NOS and sGC activity caused
significant reductions in the extent of terminal branching
and synaptogenesis by the EP cells (Figs. 8 and 9). Based on
these observations, our current hypothesis is that while the
onset of sGC expression in the EP cells coincides with their
migration, cGMP-dependent signaling does not play an
essential role in these neurons until their third phase of
motility, when each of the EP cells extends lateral branches
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onto the adjacent visceral musculature. At that time, NOS
activity within the visceral mesoderm may generate suffi-
cient NO to induce the outgrowth of terminal processes by
the EP cells and may also regulate the formation of mature
synapses. A similar mechanism may regulate the formation
of mature synaptic connections by the foregut neurons fn1,
fn2, and fn3, whose terminal branching patterns were simi-
larly reduced by inhibitors of both NOS and sGC (Fig. 8).
Because normal synapse formation obviously requires the
growth of terminal arborizations and contact with the
target regions of the muscles, it is not clear whether
synaptogenesis per se requires guanylate cyclase activity. It
should also be noted that other aspects of EP cell differen-
tiation (including the expression of transmitter phenotype)
have already commenced by this stage of development
(Copenhaver and Taghert, 1989a); the activation of NO-
sensitive sGC activity in these neurons would therefore
appear to regulate a specific aspect of their maturation
(terminal outgrowth), rather than inducing a more funda-
mental change in cellular identity.
Work on other developing systems has suggested that NO
may play an important function in the formation of mature
synaptic connections in the developing nervous system.
Based on its role in activity-dependent synaptic plasticity,
NO was initially hypothesized to act as a diffusible cue
released by target cells in response to ingrowing fibers,
thereby providing a molecular mechanism for the selective
refinement of neuronal connections (Edelman and Gally,
1992; Gally et al., 1990). Subsequent research on a variety of
preparations has indicated that the functions of NO-
mediated signaling events may actually be more diverse,
affecting the differentiation of synaptic contacts in a variety
of ways. In support of the original model for NO-mediated
synaptic refinement, Wu et al. (1994) showed that in retinal
ganglion cells the normal sequence of activity-dependent
pruning of inappropriate projections was partially disrupted
by NOS inhibitors. Similarly, NO signaling has been pro-
posed to act as a retrograde signal at the developing neuro-
muscular junction in Xenopus, where the induction of sGC
by NO appears necessary for the activity-dependent synap-
tic suppression that accompanies the elimination of extra
synapses (Wang et al., 1995). NO has also been shown in
vitro to inhibit the motility of growth cones in both dorsal
root ganglion cells (Hess et al., 1993) and retinal ganglion
neurons (Renteria and Constantine-Paton, 1996), although
these effects appear to be via a cGMP-independent mecha-
nism.
In contrast, NOS expression in vivo was found to increase
dramatically during axonal regeneration in rat dorsal root
ganglion cells (Verge et al., 1992) and olfactory receptor
neurons (Roskams et al., 1994), suggesting a possible stimu-
latory role for NO-mediated events in the control of motil-
ity. Similarly, NO donors enhanced the outgrowth of pro-
cesses from both hippocampal neurons and PC-12 cells
grown in vitro (Hindley et al., 1997). NOS–cGMP signaling
has also been proposed to regulate the biochemical matu-
ration of spinal motor neurons in response to premotor
input (Kalb and Agostini, 1993) and to mediate neuronal–
glial interactions during myelinogenesis in the rat brain
(Tanaka et al., 1997). Thus, while NOS and sGC activity
may be critical for the normal development of many regions
of the nervous system, the specific effect that this signaling
pathway has on a particular cell type may depend on the
developmental program of that cell and may be modulated
by interactions with additional intercellular signals, includ-
ing peptide hormones (Elferink and VanUffelen, 1996) and
growth factors (Hindley et al., 1997).
With respect to the EP cells in Manduca, our data suggest
that the role of NO-sensitive sGC activity may be to act as
a developmental signal that initiates the transition from
axonal elongation to lateral sprouting of terminal processes.
However, rather than acting as a synapse-specific regulator
of terminal differentiation, as has been suggested in cases of
NO-mediated elimination of inappropriate projections (Wu
et al., 1994) or synapses (Wang et al., 1995), activation of
sGC activity may induce a more general stimulation of
terminal process outgrowth on the part of NO-sensitive EP
cells. By this scenario, NO would be released into the local
vicinity of the postmigratory neurons and initiate the
formation of terminal branches. Other, more local cues
would then determine the precise placement of mature
synaptic connections on the lateral musculature. In support
for this model, the innervation patterns produced by the EP
cells do not conform to a stereotyped or predictable pattern,
but rather provide a diffuse innervation of the gut muscu-
lature in which the configuration of individual processes
can vary from animal to animal (unpublished observations).
Since only ;50% of the EP cells express inducible sGC
activity, we would expect that only this subset would be
directly regulated by the NO–cGMP signaling mechanism.
This prediction was supported by the residual levels of
synaptotagmin immunostaining that we detected on the
midgut even after treatments with NOS and sGC inhibitors
(Fig. 9). Though not yet explained, a similar mixture of
NO-sensitive and -insensitive motor neurons was found to
innervate insect skeletal muscles in locusts (Truman et al.,
1996).
Although we were unable to identify a local source of
putative NOS expression within the target muscles of the
midgut EP cells, an intensely stained band of NADPHd
activity gradually developed in the visceral mesoderm at
the foregut–midgut boundary (Fig. 3). Whereas current mod-
els of NO-mediated signaling generally assume that this gas
acts only as a short-range intercellular messenger, NO has
been shown to be capable of diffusing several hundred
microns at sufficient concentrations to exert physiologi-
cally relevant effects (Lancaster, 1994). In the developing
ENS, therefore, it is possible that NO is released from this
diaphorase-positive band of visceral mesoderm only after
the stages of migration and axonal elongation are complete,
thereby initiating the third phase of EP cell motility (ter-
minal branch formation and synaptogenesis) in an sGC-
dependent manner. Alternatively, it is possible that another
signaling molecule in addition to NO normally regulates
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sGC activity in the EP cells. In particular, CO will also
activate NO-sensitive sGCs (Pineda et al., 1996; Verma et
al., 1993), and in some instances CO has been shown to be
equally important in regulating specific physiological re-
sponses in neurons (Hawkins et al., 1994; Pineda et al.,
1996). Moreover, the developmental expression of heme
oxygenase, the primary enzyme responsible for generating
CO, colocalizes with sGC activity in many regions of the
developing vertebrate CNS where NOS expression is com-
paratively low or absent (Giuili et al., 1994; Verma et al.,
1993; Zhang and Snyder, 1992). Thus, while our results
obtained with NOS inhibitors suggest that NO may nor-
mally mediate the activation of sGC activity in the EP cells,
it will be important to examine the possible role of CO-
mediated signaling in the developing ENS as well.
A surprising result from our studies was that the EP cells
commenced the expression of detectable NO-sensitive sGC
activity shortly after migration onset (between 55 and 58%
of development) in what appeared to be a tightly regulated
manner. Nevertheless, we could detect no functional role
for this signaling pathway until almost 25% of develop-
ment later, well after migration was complete. NO has been
shown to affect the migration of neutrophils (Elferink and
VanUffelen, 1996) and the aggregation of slime mold cells
(Tao et al., 1997), and NOS activity is apparently upregu-
lated during the migration of regenerating olfactory recep-
tor neurons (Roskams et al., 1994). Nevertheless, a specific
function for inducible sGC activity in controlling the
migratory process within the nervous system has not been
shown. In contrast, a variety of postmigratory neurons
express either NOS (Bredt et al., 1990; Schilling et al., 1994)
or sGC activity (Giuili et al., 1994; Markerink-Van Ittersum
et al., 1997) at various stages of their differentiation, sug-
gesting that the developmental regulation of these mol-
ecules will vary among different cell types. With respect to
the EP cells, the appearance of sGC activity coincident with
the onset of their migration suggests that local cues asso-
ciated with the migratory pathways may induce the expres-
sion of genes encoding the sGC subunits. A similar pattern
has been observed with respect to the expression of a
neuropeptide phenotype within the EP cells, which can be
correlated with the migration of these neurons onto the
midgut musculature (Copenhaver et al., 1996; Copenhaver
and Taghert, 1989a). In the future, it should be possible to
examine whether interactions with the local environment
affect the timing of sGC expression by manipulations of the
developing ENS in embryonic culture.
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